Enzymatic biocatalyst specialist Enzymaster is to create a formal presence in the US, aided by business management consultancy Haig Barrett, which specialises in the life sciences and speciality chemicals. This will soon include facilities in the US, the company said.

Enzymaster is now launching business relationship models to address the specific needs of the North American market. These include fee-for-service models with client-centric IP constructs, development programmes including commercial manufacturing of engineered enzymes and collaborative engineering partnerships.

Nouryon plans to expand its capacity for monochloroacetic acid (MCA) at Delfzijl, Netherlands, by the end of 2020. Together with the opening of a new joint venture plant in India later this year, which will increase its global capacity by 20%.